<code id='F8D9A1E2CE'></code><style id='F8D9A1E2CE'></style>
    • <acronym id='F8D9A1E2CE'></acronym>
      <center id='F8D9A1E2CE'><center id='F8D9A1E2CE'><tfoot id='F8D9A1E2CE'></tfoot></center><abbr id='F8D9A1E2CE'><dir id='F8D9A1E2CE'><tfoot id='F8D9A1E2CE'></tfoot><noframes id='F8D9A1E2CE'>

    • <optgroup id='F8D9A1E2CE'><strike id='F8D9A1E2CE'><sup id='F8D9A1E2CE'></sup></strike><code id='F8D9A1E2CE'></code></optgroup>
        1. <b id='F8D9A1E2CE'><label id='F8D9A1E2CE'><select id='F8D9A1E2CE'><dt id='F8D9A1E2CE'><span id='F8D9A1E2CE'></span></dt></select></label></b><u id='F8D9A1E2CE'></u>
          <i id='F8D9A1E2CE'><strike id='F8D9A1E2CE'><tt id='F8D9A1E2CE'><pre id='F8D9A1E2CE'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:3
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          Why Congress must ban federal programs from using QALYs
          Why Congress must ban federal programs from using QALYs

          AdobeThirty-fiveyearsago,IwasproudtointroducetheAmericanswithDisabilitiesActintheHouseofRepresentati

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          JPM: CVS says Medicare Advantage patients are impacting profits

          WilfredoLee/APMedicareAdvantagememberscontinuetogotothedoctorandgethealthcareproceduresalotmorethanp